Pioneering Electron Wellness Technology for Human Resilience
Investigating the Next Frontier in Oxidative Stress Mitigation
Currently in prototype validation phase
It’s not a replacement for the Earth—it’s a lifeline for those who’ve been disconnected.
The Challenge We’re Addressing
Modern life bombards our bodies with oxidative stress—from electromagnetic fields, pollution, chronic stress, and environmental toxins. This cellular damage accumulates daily, impacting recovery, performance, and long-term health.
While the problem is well-documented, solutions that work automatically—without requiring daily effort or lifestyle changes—remain elusive.
Our Research Direction: OxSHIELD™
Why This Matters Now
We’re developing OxSHIELD, a wearable technology designed to deliver targeted electrons to support the body’s natural defense against oxidative stress.
The Concept: By providing bioavailable electrons directly through embedded materials, we aim to help neutralize free radicals at the cellular level—continuously and non-invasively.
Current Status: Theory validated through existing research. Prototypes in development. Clinical validation planned.
$6B+ Market Opportunity across wellness, defense, and aerospace applications
Growing Demand for non-invasive health technologies that work passively
Scientific Foundation supported by peer-reviewed research on electromagnetic fields, oxidative stress, and electron therapy
Endorsed by Space Health Leaders
Nicole Stott, NASA Astronaut (Ret.):
As an astronaut, I understand the toll that extreme environments take on the body. OxSHIELD presents a promising innovation in wearable tech aimed at mitigating oxidative stress—something I believe could have a meaningful impact both in space and here on Earth.”
— Nicole Stott, NASA Astronaut (Ret.)
Dr. Dorit Donoviel, Director, NASA TRISH:
The Translational Research Institute for Space Health (TRISH) has expressed interest in OxSHIELD for potential future missions—highlighting its alignment with NASA’s focus on astronaut health and next-generation space medicine.
— Dr. Dorit Donoviel, Director, NASA TRISH
Our Scientific Approach
Phase 1 (Current): Prototype development and initial validation
- Electron delivery mechanism refinement
- Material optimization
- Safety and efficacy testing protocols
Phase 2 (Planned): Clinical validation studies
- Biomarker measurement
- Third-party validation
- Regulatory pathway planning
Phase 3 (Future): Strategic partnerships and licensing
Platform scaling
OEM integration
Smart textile partnerships
Investment Opportunity
We’re currently raising a pre-seed round to fund prototype validation and initial clinical studies. This is an opportunity to join us at the ground floor of potentially breakthrough technology.
What Your Investment Funds:
- Prototype testing and refinement
- Clinical validation studies
- Core team expansion
- IP development and protection
Stay Connected
Interested in our research progress, partnership opportunities, or investment details?
For Investors: Use the form below to contact us about our current funding round
For Partners: Use the form below to reach out to explore collaboration opportunities
Transparency Commitment
OxSHIELD™ is currently in development. All statements about potential benefits are based on theoretical models and existing research. We are committed to rigorous validation before making definitive health claims.
The OxSHIELD device is not intended to diagnose, treat, cure, or prevent any disease. All research is preliminary and subject to clinical validation.
© 2025 Grounded Ventures LLC. All rights reserved.
OxSHIELD™ is patent-pending.
The OxSHIELD device is not intended to diagnose, treat, cure, or prevent any disease.